Targeting tumor-associated nerves enhances cancer immunotherapy.
1/5 보강
Tumor-associated nerves actively shape tumor immunity.
APA
Cao C (2025). Targeting tumor-associated nerves enhances cancer immunotherapy.. Neuron, 113(19), 3076-3078. https://doi.org/10.1016/j.neuron.2025.09.005
MLA
Cao C. "Targeting tumor-associated nerves enhances cancer immunotherapy.." Neuron, vol. 113, no. 19, 2025, pp. 3076-3078.
PMID
41038157 ↗
Abstract 한글 요약
Tumor-associated nerves actively shape tumor immunity. In a recent issue of Nature, Baruch et al. show that cancer-induced nerve injury drives T cell exhaustion and undermines PD-1 blockade. Targeting this neuro-immune crosstalk is a promising strategy to enhance cancer immunotherapy.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Advances in Delta-like Ligand 3-Targeted Diagnosis and Treatment.
- EBF3 transcriptionally activates ACADL to block the Hippo/YAP signaling pathway and inhibits breast cancer progression.
- Orchestrating tumor-immune epigenetics via SERT-H3Q5ser axis.
- A novel qualitative pattern of shear wave elastography for differentiating suspicious metastatic axillary lymph nodes on B-mode ultrasound: a multi-center retrospective study.
- tRF-34-86J8WPMN1E8Y2Q promotes the occurrence and development of gastric cancer by combining with LRAT.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.